Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Ophthalmology. 2012 Aug 17;119(12):2622–2630. doi: 10.1016/j.ophtha.2012.06.026

Figure 2. Progression to new onset ocular von Hippel-Lindau (VHL) disease during study followup.

Figure 2

(A) Of participants without ocular VHL disease in either eye at baseline, a majority (73%) remained free of ocular involvement at final follow-up. (B) Of study eyes without ocular VHL disease at baseline, the majority of eyes (78%) were disease-free at final follow-up. RCH = retinal capillary hemangioblastomas